Trials / Recruiting
RecruitingNCT07343245
A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs
A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics Drug-Drug Interaction of DW4421 and 3 NSAIDs in Healthy Adult Volunteers
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Drug-Drug Interaction between DW4421 and three different kinds of NSAIDs
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DW4421 | QD |
| DRUG | DW4421-N1 | BID |
| DRUG | DW4421-N2 | BID |
| DRUG | DW4421-N3 | QD |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2026-02-22
- Completion
- 2026-06-17
- First posted
- 2026-01-15
- Last updated
- 2026-01-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07343245. Inclusion in this directory is not an endorsement.